There have already been a few attempts by pharmaceutical companies to accelerate drug development by running clinical trials in poor countries with weaker patient protections. Regardless of the obvious ethical concerns, it turns out this doesn't actually speed up the process. It still takes just as long to discern a clear signal in terms of effects versus side effects. And those poor countries typically have infrastructure, security, and labor force problems which make it challenging to run large scale clinical trials at all.